The new main pharma innovated activities of the PH business unit is to develope a process to create genetic modified human proteins for medical needs. The main goal of the new business unit is to create a human genetic proteins for medical industries, including cosmetics.

MedicTouch - Mobile Pulse Oximeter Device (mPOD) the world’s first cellular SpO2 medical device ready for testing.
  (more…)